Shufro Rose & Co. LLC boosted its position in UnitedHealth Group Inc (NYSE:UNH) by 164.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 75,582 shares of the healthcare conglomerate’s stock after purchasing an additional 46,954 shares during the period. UnitedHealth Group comprises approximately 1.8% of Shufro Rose & Co. LLC’s portfolio, making the stock its 16th biggest holding. Shufro Rose & Co. LLC’s holdings in UnitedHealth Group were worth $18,443,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Eastern Bank lifted its stake in UnitedHealth Group by 2.0% in the second quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock valued at $16,858,000 after purchasing an additional 1,375 shares during the last quarter. Enterprise Bank & Trust Co bought a new stake in UnitedHealth Group during the 1st quarter valued at $3,785,000. Private Advisors LLC raised its holdings in UnitedHealth Group by 57.9% during the 1st quarter. Private Advisors LLC now owns 6,501 shares of the healthcare conglomerate’s stock valued at $1,607,000 after acquiring an additional 2,385 shares during the period. First City Capital Management Inc. bought a new stake in UnitedHealth Group during the 4th quarter valued at $580,000. Finally, Capital Investment Advisors LLC raised its holdings in UnitedHealth Group by 26.2% during the 2nd quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock valued at $1,556,000 after acquiring an additional 1,323 shares during the period. Institutional investors and hedge funds own 85.87% of the company’s stock.
In other news, Director William C. Ballard, Jr. sold 12,000 shares of the company’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total value of $3,063,720.00. Following the transaction, the director now owns 61,309 shares of the company’s stock, valued at $15,652,800.79. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $239.02, for a total transaction of $1,195,100.00. Following the completion of the transaction, the director now directly owns 77,993 shares in the company, valued at approximately $18,641,886.86. The disclosure for this sale can be found here. In the last ninety days, insiders sold 37,000 shares of company stock worth $9,158,720. Insiders own 0.87% of the company’s stock.
A number of brokerages have issued reports on UNH. Raymond James boosted their target price on shares of UnitedHealth Group from $265.00 to $300.00 and gave the company a “buy” rating in a report on Friday, July 19th. Royal Bank of Canada set a $311.00 target price on shares of UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. SunTrust Banks lowered their target price on shares of UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a report on Wednesday, April 17th. They noted that the move was a valuation call. Bank of America reissued a “buy” rating and set a $290.00 target price (down previously from $320.00) on shares of UnitedHealth Group in a report on Wednesday, April 17th. Finally, Morgan Stanley boosted their target price on shares of UnitedHealth Group from $285.00 to $298.00 and gave the company an “overweight” rating in a report on Friday, July 12th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $295.06.
Shares of UnitedHealth Group stock traded up $0.80 during trading on Friday, hitting $250.05. The stock had a trading volume of 2,677,617 shares, compared to its average volume of 3,780,643. The stock has a market capitalization of $236.87 billion, a price-to-earnings ratio of 17.78, a price-to-earnings-growth ratio of 1.33 and a beta of 0.61. UnitedHealth Group Inc has a 12 month low of $208.07 and a 12 month high of $287.94. The company’s 50-day moving average price is $251.52. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.73 and a current ratio of 0.67.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, topping the consensus estimate of $3.46 by $0.14. The firm had revenue of $60.60 billion for the quarter, compared to analysts’ expectations of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The business’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.14 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Inc will post 14.82 earnings per share for the current fiscal year.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Trading Ex-Dividend
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.